MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Multi-ancestry analysis of POLG variants in Parkinson’s disease

    YW. Tay, I. Elsayed, D. Yeow, M. James, S. Rowe, PJ. Kong, L. Screven, H. Chen, A. Dilliott, R. Alcalay, ZH. Fang, AH. Tan, C. Sue, L. Lange, T. Perinan (Kuala Lumpur, Malaysia)

    Objective: To investigate the genetic spectrum and prevalence of POLG variants in PD across diverse ancestries. Background: Variants in the polymerase gamma (POLG) gene are…
  • 2026 International Congress

    Exploratory Efficacy Analysis of Tavapadon Versus MAO-B Inhibitors in People With Early Parkinson’s Disease

    E. Freire Alvarez, K. Chan, J. Eubanks, J. Ma, E. Peckham (Alicante, Spain)

    Objective: To evaluate the effect of tavapadon vs monoamine oxidase B inhibitors (MAO-BIs) on motor function in people with early Parkinson’s disease (PD). Background: In…
  • 2026 International Congress

    Clinical Gait Traits and Cerebellar-PPN Functional Connectivity Abnormalities in Early and Moderate-to-Advanced PD with Gait Disturbance via Perceptual Technology and MRI

    J. Su, D. Liu, J. Shang, L. She, H. Wang, Y. Pan (Wuhan, China)

    Objective: To investigate clinical gait characteristics and cerebellar-pedunculopontine nucleus (PPN) functional connectivity (FC) changes in early-stage and moderate-to-advanced-stage Parkinson’s disease (PD) with gait disturbance using wearable…
  • 2026 International Congress

    Natural History of Sialidosis Type I: A Prospective Longitudinal Follow-Up Study of Clinical and Electrophysiological Markers

    BY. Gu, YC. Kuo, HW. Hsueh, SP. Fan, CW. Lin, CY. Chien, TK. Lin, MY. Lan, YY. Chang, NC. Lee, YH. Chien, WL. Hwu, CH. Lin (Taipei, Taiwan)

    Objective: We performed a prospective analysis to determine the natural history as well as changes of electrophysiological markers in a cohort of Sialidosis type I.…
  • 2026 International Congress

    Digitizing PD Rating Scales Increases Reliability and Accessibility

    Z. Yekutieli, Y. Yahalom, P. Lewitt (Tel-Aviv, Israel)

    Objective: Eliminate intra- and inter-rater variability by using digital means for rating scales and making them accessible for all. Background: Conventional clinician-rated scales like UPDRS…
  • 2026 International Congress

    Multicenter Evaluation of Automated Structural MRI-based Diagnosis for Multiple System Atrophy

    K. Kawabata, H. Takeshige-Amano, T. Hatano, T. Baba, A. Takeda, S. Kuwabara, A. Ogura, M. Katsuno, R. Hanajima, M. Matsushima, I. Yabe, M. Hatakeyama, O. Onodera, H. Watanabe (Toyoake, Japan)

    Objective: This study aims to evaluate whether automated classification based on individual voxel-based morphometry (VBM) adjusting covariates (iVAC) can achieve high diagnostic accuracy for MSA…
  • 2026 International Congress

    Cell-type-specific asynchronous aging acceleration across movement disorders

    X. Chen, W. Du, J. Luo, G. Liu (Shenzhen, China)

    Objective: To quantify brain cell-type–specific biological aging across different movement disorders (MDS) and compare similarities and differences in cellular aging patterns among MDS. Background: It…
  • 2026 International Congress

    Comparative Effectiveness of Tavapadon Versus Real-world Oral Standard of Care Treatments in Parkinson’s Disease With Motor Fluctuations: an Indirect Comparison Analysis

    P. Agarwal, R. Pahwa, A. Fasano, H. Deng, C. Yan, L. Harmer, S. Huang, K. Onuk, A. Espay (Kirkland, USA)

    Objective: To compare clinical-trial tavapadon with real-world oral standard of care (SoC) in patients with Parkinson’s disease (PD) experiencing motor fluctuations. Background: In the phase…
  • 2026 International Congress

    A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson’s disease symptoms

    C. Moreau, F. Marchand, J. Bene, C. Leclercq, V. Foutel, M. Fisichella, D. Devos (Lille, France)

    Objective: To investigate the safety and efficacy of continuous circadian and personalized intracerebroventricular (i.c.v.) administration of anaerobic dopamine (A-dopamine) in Parkinson's disease patients refractory to…
  • 2026 International Congress

    Does Fall-Related Activity Avoidance Differ between people with Parkinson’s disease versus Cognitively Unimpaired Controls?

    M. Lindh-Rengifo, E. Franzén, M. Landers, E. Stomrud, M. Nilsson (Malmö, Sweden)

    Objective: investigate whether fall-related activity avoidance differs between people with Parkinson’s disease (PD) versus cognitively unimpaired controls (CU) without any significant neurological disease. Background: Although…
  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley